Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer

[1]  Lingli Chen,et al.  Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma , 2020, Cancer management and research.

[2]  L. Shen,et al.  Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP , 2018, World journal of gastroenterology.

[3]  Y. Hu,et al.  Efficacy and safety for Apatinib treatment in advanced gastric cancer: a real world study , 2017, Scientific Reports.

[4]  M. Ikegami,et al.  Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: A case report. , 2017, Oncology letters.

[5]  Y. Bozkaya,et al.  Clinicopathological and prognostic characteristics in patients with AFP-secreting gastric carcinoma. , 2017, Molecular and clinical oncology.

[6]  X. Zhang,et al.  [The prognosis and clinicopathological characteristics of 70 gastric cancer patients with elevated serum AFP]. , 2017, Zhonghua zhong liu za zhi [Chinese journal of oncology].

[7]  Lizong Shen,et al.  Clinicopathologic and prognostic characteristics of alpha-fetoprotein–producing gastric cancer , 2017, Oncotarget.

[8]  Ying Cheng,et al.  Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Siyu Chen,et al.  A case report of targeted therapy with apatinib in a patient with advanced gastric cancer and high serum level of alpha-fetoprotein , 2016, Medicine.

[10]  Tao Qu,et al.  PRISMA-Compliant Article: Clinical Characteristics and Factors Influencing Prognosis of Patients With Hepatoid Adenocarcinoma of the Stomach in China , 2016, Medicine.

[11]  F. Roviello,et al.  Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer. , 2016, Cancer letters.

[12]  S. Qin,et al.  Successful multimodal therapy for an α-fetoprotein-producing gastric cancer patient with simultaneous liver metastases. , 2015, Oncology letters.

[13]  T. Liang,et al.  AFP (alpha fetoprotein): who are you in gastrology? , 2015, Cancer letters.

[14]  Hun Jung,et al.  Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer. , 2014, Hepato-gastroenterology.

[15]  Jun Wu,et al.  Characteristic analysis of α-fetoprotein-producing gastric carcinoma in China , 2013, World Journal of Surgical Oncology.

[16]  Ying Cheng,et al.  Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  J. Atallah,et al.  Alpha-Fetoprotein-Producing Nonmetastatic Gastric Adenocarcinoma: A Rare Entity , 2013, Journal of Gastrointestinal Cancer.

[18]  T. Goi,et al.  Five-Year Survival of Alpha-Fetoprotein-Producing Gastric Cancer with Synchronous Liver Metastasis: A Case Report , 2013, Journal of gastric cancer.

[19]  K. Fukuda,et al.  [Retrospective analysis concerning AFP-producing gastric cancer]. , 2013, Gan to kagaku ryoho. Cancer & chemotherapy.

[20]  T. Gotoda,et al.  Histologic and Immunohistochemical Analyses of &agr;-Fetoprotein—Producing Cancer of the Stomach , 2012, The American journal of surgical pathology.

[21]  Y. Bang,et al.  Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer , 2011, BMC gastroenterology.

[22]  Takefumi Nakamura,et al.  [A case of AFP-producing gastric cancer resected after efficient S-1/CDDP combination chemotherapy]. , 2011, Gan to kagaku ryoho. Cancer & chemotherapy.

[23]  M. Rugge,et al.  Hepatoid Adenocarcinoma of the Colon: What Should We Target? , 2011, Pathology & Oncology Research.

[24]  W. Sheng,et al.  Clinicopathologic features and prognostic factors in alpha‐fetoprotein‐producing gastric cancers: Analysis of 104 cases , 2010, Journal of surgical oncology.

[25]  A. Reiter,et al.  Hepatoid Adenocarcinoma – Review of the Literature Illustrated by a Rare Case Originating in the Peritoneal Cavity , 2010, Oncology Research and Treatment.

[26]  Tadao Tanaka,et al.  Alpha-fetoprotein (AFP)-producing ovarian tumor in an elderly woman , 2009, International Journal of Clinical Oncology.

[27]  M. Moriyama,et al.  [A case of alpha-fetoprotein-producing gastric cancer with hepatic metastasis successfully treated with combination chemotherapy]. , 2008, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[28]  M. Kodama,et al.  Alpha-Fetoprotein-Producing Early Gastric Cancer of the Remnant Stomach: Report of a Case , 2007, Surgery Today.

[29]  K. Notohara,et al.  Hepatoid carcinoma of the pancreas producing protein induced by vitamin K absence or antagonist II (PIVKA-II) and α-fetoprotein (AFP) , 2006, Journal of Gastroenterology.

[30]  M. Ichinose,et al.  A case of primary lung cancer producing alpha-fetoprotein. , 2004, Canadian respiratory journal.

[31]  I. Hyodo,et al.  Unresectable alpha fetoprotein-producing gastric cancer successfully treated with irinotecan and mitomycin C after S-1 failure. , 2004, Internal medicine.

[32]  J. Feinglass,et al.  Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. , 2003, Surgery.

[33]  H. Fujii,et al.  Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing α-fetoprotein , 2003, Journal of Gastroenterology.

[34]  Takuma Sasaki,et al.  Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  M. Tsuneyoshi,et al.  Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis , 1993, Cancer.

[36]  N. Nagasue,et al.  Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. , 1992, The American journal of gastroenterology.

[37]  H. Ishikura,et al.  An AFP‐producing gastric carcinoma with features of hepatic differentiation. A case report , 1985, Cancer.

[38]  T. Waldmann,et al.  Serum alpha-fetoprotein in patients with neoplasms of the gastrointestinal tract. , 1975, Cancer research.

[39]  A. Fondimare,et al.  [Existence of alpha feto protein during gastric-origin secondary cancer of the liver]. , 1970, La Presse medicale.

[40]  C G BERGSTRAND,et al.  Demonstration of a new protein fraction in serum from the human fetus. , 1956, Scandinavian journal of clinical and laboratory investigation.